None of BPC-157, TB-500, or GHK-Cu is FDA-approved as a drug, and BPC-157 in particular has been the subject of regulatory attention regarding compounding
But without a functional repair signal and enough blood flow to the area, some injuries don't heal they stabilize in a damaged state
This peptide fragment is intended for use by qualified professionals conducting structured research within appropriate laboratory environments
The support of healthy heart functions
It works directly on fat cells, breaking down stored triglycerides and blocking new fat from forming
The Bottom Line GHK-Cu sits in a strange spot in the peptide research world genuinely old research (Pickart's earliest work goes back to the 1970s), genuinely broad mechanistic reach (thousands of modulated genes), but still a compound where the human clinical trial base lags behind the mechanistic and cell-culture data